Tretoquinol
| |
| Names | |
|---|---|
| IUPAC name
(1S)-1-[(3,4,5-Trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
| MeSH | Tretoquinol |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C19H23NO5 | |
| Molar mass | 345.39 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
|
WikiDoc Resources for Tretoquinol |
|
Articles |
|---|
|
Most recent articles on Tretoquinol Most cited articles on Tretoquinol |
|
Media |
|
Powerpoint slides on Tretoquinol |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tretoquinol at Clinical Trials.gov Clinical Trials on Tretoquinol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tretoquinol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tretoquinol Discussion groups on Tretoquinol Patient Handouts on Tretoquinol Directions to Hospitals Treating Tretoquinol Risk calculators and risk factors for Tretoquinol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tretoquinol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tretoquinol is a beta-adrenergic agonist.[1][2]
References
- ↑ "ScienceDirect.com — Tetrahedron — Synthesis of 6,7-dihydrox-1,2,3,4-tetrahydroisoquinoline derivatives". Dx.doi.org. Retrieved 2012-08-20.
- ↑ "β-Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human β-Adrenoceptors Expressed in Chinese Hamster Ovary Cells". Jpet.aspetjournals.org. 1999-11-01. Retrieved 2012-08-20.
